Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-10

Clinical Trial Update: Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating citalopram for repetitive behaviors in children with autism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citalopram (Citalopram hydrobromide)

Snippet

Sponsor: Boston University | Conditions: Autistic Disorder | Phase 2 | Status: COMPLETED